Call for Ideas in Radiopharmaceuticals

CQDM and CPDC are pleased to announce the launch of the 2026 Call for Ideas: New Canadian Approaches in Radiopharmaceuticals, a national initiative designed to identify and support innovative Canadian technologies, discoveries, and companies that can contribute to the next generation of radiopharmaceuticals.

Canada has developed internationally recognized expertise across the radiopharmaceutical value chain, from target discovery and isotope production to clinical development and commercialization. Through this initiative, CQDM and CPDC seek to discover emerging Canadian innovations and connect promising teams with CPDC’s scientific experts and investment team.

CPDC has played a key role in the creation and growth of globally recognized Canadian radiopharmaceutical companies, including Fusion Pharmaceuticals and AtomVie Global Radiopharma. This Pitch Day will provide selected participants with a unique opportunity to receive feedback from CPDC, and to explore potential direct Seed and Series A investment, in-licensing, and collaboration opportunities in the radiopharmaceutical space.

In addition, CQDM will offer guidance to selected participants interested in pursuing non-dilutive funding opportunities through relevant CQDM programs, including SynergiQc and/or others.

Selected applicants will be invited to present their technology, company, or research program to CPDC’s scientific experts and investment team during a virtual CQDM-CPDC Pitch Day. Please note that this call for ideas is not a grant competition.

Submission deadline is October 15, 2026. All submissions will be reviewed jointly by CQDM and CPDC.